The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals
Abstract
The molecules known as bis(thiosemicarbazones) derived from 1,2-diones can act as tetradentate ligands for Cu(II), forming stable, neutral complexes. As a family, these complexes possess fascinating biological activity. This critical review presents an historical perspective of their progression from potential chemotherapeutics through to more recent applications in nuclear medicine. Methods of synthesis are presented followed by studies focusing on their potential application as anti-cancer agents and more recent investigations into their potential as therapeutics for Alzheimer's disease. The Cu(II) complexes are of sufficient stability to be used to coordinate copper radioisotopes for application in diagnostic and therapeutic radiopharmaceuticals. Detailed understanding of the coordination chemistry has allowed careful manipulation of the metal based properties to engineer specific biological activities. Perhaps the most promising complex radiolabelled with copper radioisotopes to date is Cu(II)(atsm), which has progressed to clinical trials in humans (162 references).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009
Anastasi, A., Erspamer, V., & Bucci, M. (1971) · Experientia · doi:10.1007/bf02145873 · Cited by 931
Fatty acid synthase, a proficient multifunctional enzyme
Wakil, S. J. (1989) · Biochemistry · doi:10.1021/bi00437a001 · Cited by 820
The Wide Pharmacological Versatility of Semicarbazones, Thiosemicarbazones and Their Metal Complexes
(2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487484 · Cited by 777
Reactive oxygen species: oxidative damage and pathogenesis
Bandyopadhyay, U., Das, D. K., & Banerjee, R. K. (1999) · Cited by 695
Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672
Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751219.x · Cited by 641
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
Efficient production of high specific activity 64Cu using a biomedical cyclotron
McCarthy, D. W., Shefer, R. E., Klinkowstein, R. E., Bass, L. A., Margeneau, W. H., Cutler, C. S., Anderson, C. J., & Welch, M. J. (1997) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00157-6 · Cited by 533
Krohn, K. A., Link, J. M., & Mason, R. P. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045914 · Cited by 506
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., & Yokoyama, A. (1997) · PubMed · Cited by 481
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., & Griffin, T. W. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463
Copper radionuclides and radiopharmaceuticals in nuclear medicine
Blower, P. J., Lewis, J. S., & Zweit, J. (1996) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00130-8 · Cited by 406
Copper Mediates Dityrosine Cross-Linking of Alzheimer's Amyloid-β
Atwood, C. S., Perry, G., Zeng, H., Kato, Y., Jones, W. D., Ling, K.-Q., Huang, X., Moir, R. D., Wang, D., Sayre, L. M., et al. (2004) · Biochemistry · doi:10.1021/bi0358824 · Cited by 371
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Dehdashti, F., Mintun, M. A., Lewis, J. S., Bradley, J., Govindan, R., Laforest, R., Welch, M. J., & Siegel, B. A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1130-4 · Cited by 368
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis, J. S., Mccarthy, D. W., McCarthy, T. J., et al. (1999) · PubMed · Cited by 323
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert, M., Machulla, H. ‐., Picchio, M., Reischl, G., Ziegler, S. I., Kumar, P., Wester, H.-J., Beck, R., McEwan, A. J. B., Wiebe, L. I., et al. (2005) · PubMed · Cited by 319
A marker for hypoxic cells in tumours with potential clinical applicability
Chapman, J. D., Franko, A. J., & Sharplin, J. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.79 · Cited by 306
White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
White, A. R., Reyes, R., Mercer, J. F. B., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01861-2 · Cited by 282
Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation
Crouch, P. J., Hung, L. W., Adlard, P. A., Cortes, M., Lal, V., Filiz, G., Perez, K. A., Nurjono, M., Caragounis, A., Du, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809057106 · Cited by 278
Self-citationCopper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Welch, M. J., & Blower, P. J. (2002) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100291 · Cited by 277
Structure of the Alzheimer's Disease Amyloid Precursor Protein Copper Binding Domain
Barnham, K. J., McKinstry, W. J., Multhaup, G., Galatis, D., Morton, C. J., Curtain, C. C., Williamson, N. A., White, A. R., Hinds, M. G., Norton, R. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300629200 · Cited by 275
Inhibition of Tumor Promotion by a Biomimetic Superoxide Dismutase
Kensler, T. W., Bush, D. M., & Kozumbo, W. J. (1983) · Science · doi:10.1126/science.6857269 · Cited by 250
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia
Vāvere, A. L., & Lewis, J. S. (2007) · Dalton Transactions · doi:10.1039/b705989b · Cited by 245
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 241
West, D. X., Swearingen, J. K., Valdés-Martı́nez, J., Hernández-Ortega, S., El-Sawaf, A. K., van Meurs, F., Castiñeiras, A., Garcia, I., & Bermejo, E. (1999) · Polyhedron · doi:10.1016/s0277-5387(99)00210-7 · Cited by 228
Teicher, B. A., Holden, S. A., Al-Achi, A., & Herman, T. S. (1990) · PubMed · Cited by 225
Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapy
Lewis, J. S., Laforest, R., Buettner, T. L., Song, S.-K., Fujibayashi, Y., Connett, J. M., & Welch, M. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1206 · Cited by 213
Dehdashti, F., Grigsby, P. W., Lewis, J. S., Laforest, R., Siegel, B. A., & Welch, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048520 · Cited by 212
Hypoxic Sensitizers — Implications for Radiation Therapy
Chapman, J. D. (1979) · New England Journal of Medicine · doi:10.1056/nejm197912273012606 · Cited by 210
Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q.-X., Masters, C. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 195
Self-citationXiao, Z., Donnelly, P. S., Zimmermann, M., & Wedd, A. G. (2008) · Inorganic Chemistry · doi:10.1021/ic702440e · Cited by 188
Self-citationAn Imaging Comparison of 64Cu-ATSM and 60Cu-ATSM in Cancer of the Uterine Cervix
Lewis, J. S., Laforest, R., Dehdashti, F., Grigsby, P. W., Welch, M. J., & Siegel, B. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051326 · Cited by 187
Lewis, J. S., Sharp, T. L., Laforest, R. A., Fujibayashi, Y., & Welch, M. J. (2001) · PubMed · Cited by 187
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes
Smith, C. J., Volkert, W. A., & Hoffman, T. J. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.005 · Cited by 181
Yuan, H., Schroeder, T., Bowsher, J. E., Hedlund, L. W., Wong, T. Z., & Dewhirst, M. W. (2006) · PubMed · Cited by 167
Chen, X., Park, R. J.-H., Hou, Y., et al. (2004) · PubMed · Cited by 159
Some pharmacological actions of alytesin and bombesin
Erspamer, V., Erspamer, G. F., & Inselvini, M. (1970) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1970.tb08465.x · Cited by 153
Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., & Karlin, K. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803908 · Cited by 149
Obata, A., Yoshimi, E., Waki, A., Lewis, J. S., Oyama, N., Welch, M. J., Saji, H., Yonekura, Y., & Fujibayashi, Y. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988502 · Cited by 139
Green, M. A., Klippenstein, D. L., & Tennison, J. R. (1988) · PubMed · Cited by 131
Green, M. A., Mathias, C. J., Welch, M. J., et al. (1990) · PubMed · Cited by 130
Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
Schugar, H. J., Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Böhmerle, K., Thomas, F. C., Allen, D. D., Lockman, P. R., Merkel, M., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603866 · Cited by 112
Basic characterization of 64Cu-ATSM as a radiotherapy agent
Obata, A., Kasamatsu, S., Lewis, J. S., Furukawa, T., Takamatsu, S., Toyohara, J., Asai, T., Welch, M. J., Adams, S. G., Saji, H., et al. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.08.012 · Cited by 109
Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions
Tannock, I. F., & Guttman, P. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.37 · Cited by 109
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Rae, M. T., Zweit, J., & Blower, P. J. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050283 · Cited by 108
Burgman, P., O’Donoghue, J. A., Lewis, J. S., Welch, M. J., Humm, J. L., & Ling, C. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.003 · Cited by 101
Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., Masters, C. L., Li, Q., & Bush, A. I. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.010 · Cited by 97
Copper catalyzed oxidation of Alzheimer Abeta.
Atwood, C. S., Huang, X., Khatri, A., Scarpa, R. C., Kim, Y. S., Moir, R. D., Tanzi, R. E., Roher, A. E., & Bush, A. I. (2000) · PubMed · Cited by 89
Dence, C. S., Ponde, D. E., Welch, M. J., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.06.001 · Cited by 85
Fodero‐Tavoletti, M. T., Villemagne, V. L., Paterson, B. M., White, A. R., Li, Q., Camakaris, J., O'Keefe, G. J., Cappai, R., Barnham, K. J., & Donnelly, P. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1359 · Cited by 83
Self-citationGrigsby, P. W., Malyapa, R. S., Higashikubo, R., Schwarz, J. K., Welch, M. J., Huettner, P. C., & Dehdashti, F. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0095-2 · Cited by 83
Mathias, C. J., Welch, M. J., Raichle, M. E., Mintun, M. A., Lich, L. L., McGuire, A. H., Zinn, K. R., John, E. K., & Green, M. A. (1990) · PubMed · Cited by 71
Herrero, P., Markham, J., Weinheimer, C. J., Anderson, C. J., Welch, M. J., Green, M. A., & Bergmann, S. R. (1993) · Circulation · doi:10.1161/01.cir.87.1.173 · Cited by 68
Yoshii, Y., Furukawa, T., Kiyono, Y., Watanabe, R., Mori, T., Yoshii, H., Asai, T., Okazawa, H., Welch, M. J., & Fujibayashi, Y. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.08.009 · Cited by 63
Matsumoto, K., Szajek, L. P., Krishna, M. C., et al. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.873 · Cited by 61
Tanaka, T. Q., Furukawa, T., Fujieda, S., Kasamatsu, S., Yonekura, Y., & Fujibayashi, Y. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.05.005 · Cited by 57
Vāvere, A. L., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.11.012 · Cited by 56
Aft, R., Lewis, J. S., Zhang, F., Kim, J., & Welch, M. J. (2003) · PubMed · Cited by 56
Myers, R. B., Oelschlager, D. K., Weiss, H. L., Frost, A. R., & Grizzle, W. E. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66596-2 · Cited by 52
Orientation and mobility of a copper square-planar complex in a lipid bilayer
Subczynski, W. K., Antholine, W. E., Hyde, J. S., & Petering, D. H. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00235a007 · Cited by 50
Yoshii, Y., Furukawa, T., Kiyono, Y., Watanabe, R., Waki, A., Mori, T., Yoshii, H., Oh, M., Asai, T., Okazawa, H., et al. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.12.011 · Cited by 46
Liu, J., Hajibeigi, A., Ren, G., Lin, M., Siyambalapitiyage, W., Liu, Z., Simpson, E. R., Parkey, R. W., Sun, X., & Öz, O. K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.061879 · Cited by 46
Weeks, A. J., Paul, R. L., Marsden, P. K., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1305-8 · Cited by 42
Lim, S., Price, K. A., Chong, S., Paterson, B. M., Caragounis, A., Barnham, K. J., Crouch, P. J., Peach, J. M., Dilworth, J. R., White, A. R., et al. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0587-4 · Cited by 40
Self-citationPrice, K. A., Caragounis, A., Paterson, B. M., Filiz, G., Volitakis, I., Masters, C. L., Barnham, K. J., Donnelly, P. S., Crouch, P. J., & White, A. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9007938 · Cited by 40
Self-citationVaupel, P. W., Thews, O., Kelleher, D. K., & Konerding, M. A. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.795 · Cited by 32
Antioxidative properties of copper(II) complexes
Díaz, A., Villalonga, R., & Cao, R. (2008) · Journal of Coordination Chemistry · doi:10.1080/00958970802474755 · Cited by 29
Interpretation of the sod-like activity of a series of copper(II) complexes with thiosemicarbazones
Díaz, A., Cao, R., Fragoso, A., & Sánchez, I. S. (1999) · Inorganic Chemistry Communications · doi:10.1016/s1387-7003(99)00093-3 · Cited by 27
Bica, L., Meyerowitz, J., Parker, S. J., Caragounis, A., Du, T., Paterson, B. M., Barnham, K. J., Crouch, P. J., White, A. R., & Donnelly, P. S. (2010) · BioMetals · doi:10.1007/s10534-010-9380-7 · Cited by 23
Self-citationCappuccino, J. G., Banks, S., Brown, G., George, M., & Tarnowski, G. S. (1967) · PubMed · Cited by 18
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
Cited by
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Copper complexes as therapeutic agents
Duncan, C., & White, A. R. (2012) · Metallomics · doi:10.1039/c2mt00174h · Cited by 294
Metadata
- Authors
- Paterson, B. M., & Donnelly, P. S.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2011
- Volume
- 40
- Issue
- 5
- Pages
- 3005
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2160425502
- Cited by
- 299
- References
- 82
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.